Day One Biopharmaceuticals (NASDAQ:DAWN) Stock Price Down 5%

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Rating) was down 5% during trading on Monday . The stock traded as low as $12.98 and last traded at $13.00. Approximately 319,237 shares were traded during mid-day trading, a decline of 57% from the average daily volume of 742,813 shares. The stock had previously closed at $13.68. […]

Related Keywords

United States ,America ,Samuelc Blackman ,Jeremy Bender ,Blackrock Inc ,Pricet Rowe Associates Inc ,Goldman Sachs Group Inc ,Day One Biopharmaceuticals Inc ,Needham Company ,Securities Exchange Commission ,Nasdaq ,Day One Biopharmaceuticals ,Get Rating ,One Financial ,One Biopharmaceuticals ,Day One ,Exchange Commission ,Street Corp ,Sachs Group ,Day One Biopharmaceuticals Daily ,Nasdaq Dawn ,Dawn ,Medical ,Stocks ,Technicals ,